Clinical Trial Update: Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BT8009-100 in nectin-4 expressing advanced malignancies (Phase 1/2) with status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Cancer Hr-positive
• Breast Cancer Hr-positive Low
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Solid Tumors
• Triple-negative Breast Cancer
• Urinary Bladder Cancer

Drugs mentioned

• BT8009

Snippet

Sponsor: BicycleTx Limited | Conditions: Urinary Bladder Neoplasm, Triple Negative Breast Neoplasms | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING